Lexicon Pharmaceuticals has found its new corporate headquarters and will be occupying 25,288 square feet at 2445 Technology Forest Blvd. in The Woodlands. Lexicon Pharmaceuticals is a biopharmaceutical company that applies a unique approach to gene science.

NAI Partners’ Dan Boyles and Jon Silberman represented Lexicon Pharmaceuticals in the transaction. The duo had previously sold the company’s corporate campus at 8800 Technology Forest for Lexicon at the end of last year. This was the single-largest commercial real estate sales transaction in the life sciences sector in the Greater Houston area in 2020.

“Following the sale of 8800 Technology Forest, Lexicon knew it wanted to remain in The Woodlands, and we were pleased to find high-end office space that was representative of the company’s stature as one Houston’s premier life sciences organizations and also a stone’s throw away from their previous headquarters, ensuring business continuity,” said Boyles.

Lexicon leverages technology to discover and develop precise medicines for people with serious chronic conditions. Using a patient-driven approach, the company is working to discover and develop innovative medicines to safely and effectively treat disease and improve patient lives.